Precision Business Insights
Portfolio

 

Research Reports

Wound Biofilm Therapeutics Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Wound Biofilm Therapeutics Market

 

Global wound biofilm therapeutics market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over the 2018 to 2024

 

Market Outline: Global Wound Biofilm Therapeutics Market

Wound biofilm therapeutics are used to combat the wound biofilms that are a type of infection made up of living microorganisms by forming colonies. These are caused by various species such as fungi, bacteria, yeast, algae, and other microorganisms. Biofilm is formed when microbes attached themselves to surface of wounds by secreting gummy substance. Formation of biofilms leads to chronic infection and non-healing wounds. Wound biofilms occurs on the chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure or decubitus ulcers, and surgical site infections. Most of the Wound Biofilm Therapeutics Market players are focused on the R&D activities for the innovation of newer platforms to cure the wound biofilms. For instance,

  • A Washington State University research team successfully used mild current to beat drug-resistant bacterial infection, that may use to treat chronic wounds.
  • Soring GmbH developed Ultrasonic-Assisted Wound Debridement (UAW) that uses the cavitation effect. The ultrasonic vibrations of UAW generates the cavitation bubbles in irrigation solution. Strong sonic shock waves or microjets are developed due to implode of cavitation bubbles that disrupts the wound biofilms by removing the devitalized tissue and foreign bodies
  • ProclaRx developed a new platform that cure the wound biofilms by binding of antibody to proteins in bacterial biofilms. The ProclaRx biologic pulls the protein out of biofilm matrix leads to causing the matrix fall apart and exposed bacteria can be eradicated. Company developing the antibody used as a topical adjunct in the treatment of secretory otitis media and patients with CVID chronic sinusitis.
  • Integrated Healing Technologies’s received FDA 510 (k) clearance for its patented NewEra REVA negative pressure wound therapy (NPWT) system that incorporates hypochlorous acid wound wash, OhaseOne that is 80-100 times more effective than Dakin’s Solution and shows in-vitro to disrupt bacterial biofilms

 

Key Features of the Wound Biofilm Therapeutics Market Report:

  • The Wound Biofilm Therapeutics Market report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the Wound Biofilm Therapeutics Market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  • 3m Health Information Systems (U.S)
  • Medic4all (Switzerland)
  • MindChild Medical (U.S)
  • Medtronic Inc. (U.S)
  • Siemens Healthcare (Germany)
  • Agfa Healthcare Nv (Belgium)
  • Alcatel-Lucent, Cisco, Amd Telemedicine Inc. (U.S)
  • American Telecare Inc. (U.S)
  • Aerotel Medical Systems Ltd. (Israel)
  • International Business Machines Corp. (U.S)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials